Filtered By:
Specialty: Hematology
Procedure: Transplants
This page shows you your search results in order of relevance. This is page number 18.
Order by Relevance | Date
Total 261 results found since Jan 2013.
Hematopoietic Cell Transplant Outcomes among Medicaid and Privately Insured Patients with Sickle Cell Disease
Sickle cell disease (SCD) is the most common inherited hemoglobin disorder affecting approximately 100,000 people in the United States (U.S.), a majority of whom are Black/African American, with an incidence rate of 1 in every 365 births.1 SCD is a chronic health condition associated with acute painful vaso-occlusive crisis (VOC), acute chest syndrome (ACS), stroke, chronic organ damage and culminates in a life expectancy that is less than half that of the general American population.2-4
Source: Biology of Blood and Marrow Transplantation - April 21, 2021 Category: Hematology Authors: Tatenda G. Mupfudze, Christa Meyer MS, Jaime M. Preussler, Lih-Wen Mau, Yung-Tsi Bolon, Patricia Steinert, Staci D. Arnold, Wael Saber, Lakshmanan Krishnamurti Source Type: research
Hematopoietic Cell Transplantation Outcomes among Medicaid and Privately Insured Patients with Sickle Cell Disease
Sickle cell disease (SCD) is the most common inherited hemoglobin disorder, affecting approximately 100,000 people in the United States, a majority of whom are Black/African American, with an incidence rate of 1 in every 365 births [1]. SCD is a chronic health condition associated with acute painful vaso-occlusive crisis (VOC), acute chest syndrome (ACS), stroke, and chronic organ damage and culminates in a life expectancy that is less than one-half that of the general American population [2 –4].
Source: Biology of Blood and Marrow Transplantation - April 21, 2021 Category: Hematology Authors: Tatenda G. Mupfudze, Christa Meyer, Jaime M. Preussler, Lih-Wen Mau, Yung-Tsi Bolon, Patricia Steinert, Staci D. Arnold, Wael Saber, Lakshmanan Krishnamurti Source Type: research
ROTEM Testing for Direct Oral Anticoagulants
This article reviews the use of ROTEM in the setting of DOACs therapy, focusing on DOACs-associated bleeding and the use of this VHA for the management of reversal strategies for DOACs-associated anticoagulation. [...] Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAArticle in Thieme eJournals: Table of contents | Abstract | Full text
Source: Seminars in Thrombosis and Hemostasis - June 15, 2021 Category: Hematology Authors: Korpallov á, Barbora Samo š, Matej Bolek, Tom áš K ühnelová, Linda Škorňová, Ingrid Kubisz, Peter Sta ško, Ján Mok áň, Marián Tags: Review Article Source Type: research
Low Rates of Cerebral Infarction after Hematopoietic Stem Cell Transplantation in Patients with Sickle Cell Disease at High Risk for Stroke
(CNS)
Source: Biology of Blood and Marrow Transplantation - September 13, 2021 Category: Hematology Authors: Jessica L. Carpenter, Robert S. Nickel, Jennifer Webb, Zarir Khademian, Barbara Speller-Brown, Suvankar Majumdar, Deepika S. Darbari, Andrew Campbell, Anqing Zhang, Allistair Abraham Source Type: research
Neuropathy and Muscle Cramps in Autologous and Allogeneic Hematopoietic Cell Transplantation Survivors
Hematopoietic cell transplantation (HCT) is a critical part of the armamentarium in the treatment of many hematologic malignancies. However, both allogeneic and autologous HCT may be associated with high morbidity in survivors. Neurological complications of HCT that may have long-term impact on quality of life (QOL) are often overlooked.1 Both the central nervous system (CNS) and peripheral nervous system (PNS) can be involved with CNS complications including infections, posterior reversible encephalopathy syndrome (PRES), seizures, and stroke being more prominent in the acute post-HCT period,2 and PNS complications such a...
Source: Biology of Blood and Marrow Transplantation - June 15, 2022 Category: Hematology Authors: Tanya Lehky, Iago Pinal Fernandez, Elizabeth F. Krakow, Laura Connelly-Smith, Rachel B. Salit, Phuong Vo, Masumi Ueda Oshima, Lynn Onstad, Paul A. Carpenter, Mary E. Flowers, Stephanie J Lee Source Type: research
Independent risk factors for an increased incidence of thromboembolism after lung transplantation
ConclusionsThe incidence of TE after LTX is high, especially in lung transplant recipients with a BMI > 25 and an age > 55 years as well as cardiovascular risk factors closely associated with the metabolic syndrome. As these patients comprise a growing recipient fraction, intensified research should focus on the risks and benefits of regular screening or a prolonged TE prophylaxis in these patients.Trial registration number DKRS: 00021501.
Source: Journal of Thrombosis and Thrombolysis - December 10, 2022 Category: Hematology Source Type: research
